Fig. 2.
Analysis of relationship between pre- and post-switch erythropoiesis-stimulating agent dose. 1:1 reference line indicates equal PEG-Epo and darbepoetin alfa doses. EP evaluation period, PEG-Epo methoxy polyethylene glycol-epoetin beta
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.